OA06274A - Procédé de préparation de nouveaux composés de type muramyl-péptide. - Google Patents

Procédé de préparation de nouveaux composés de type muramyl-péptide.

Info

Publication number
OA06274A
OA06274A OA56827A OA56827A OA06274A OA 06274 A OA06274 A OA 06274A OA 56827 A OA56827 A OA 56827A OA 56827 A OA56827 A OA 56827A OA 06274 A OA06274 A OA 06274A
Authority
OA
OAPI
Prior art keywords
muramyl
preparation
novel compounds
peptide type
peptide
Prior art date
Application number
OA56827A
Other languages
English (en)
French (fr)
Inventor
Pierre Lefrancier
Monique Parant
Francois Audibert
Louis Chedid
Jean Choay
Edgar Lederer
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Publication of OA06274A publication Critical patent/OA06274A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
OA56827A 1978-06-05 1979-06-05 Procédé de préparation de nouveaux composés de type muramyl-péptide. OA06274A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7816793A FR2428051A1 (fr) 1978-06-05 1978-06-05 Nouveaux composes du type muramyl-peptide et medicaments les contenant

Publications (1)

Publication Number Publication Date
OA06274A true OA06274A (fr) 1981-06-30

Family

ID=9209095

Family Applications (1)

Application Number Title Priority Date Filing Date
OA56827A OA06274A (fr) 1978-06-05 1979-06-05 Procédé de préparation de nouveaux composés de type muramyl-péptide.

Country Status (21)

Country Link
US (1) US4693998A (ru)
EP (1) EP0006068B1 (ru)
JP (1) JPS55392A (ru)
AR (1) AR228240A1 (ru)
AT (1) ATE4719T1 (ru)
AU (1) AU536516B2 (ru)
CA (1) CA1249700A (ru)
CS (1) CS221505B2 (ru)
DD (1) DD145274A5 (ru)
DE (1) DE2966178D1 (ru)
DK (1) DK150147C (ru)
EG (1) EG14154A (ru)
ES (1) ES481785A1 (ru)
FR (1) FR2428051A1 (ru)
HU (1) HU184041B (ru)
IL (1) IL57476A (ru)
MA (1) MA18474A1 (ru)
OA (1) OA06274A (ru)
PL (1) PL123483B1 (ru)
PT (1) PT69725A (ru)
SU (2) SU1326197A3 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
JPS5784223A (en) * 1980-11-13 1982-05-26 Nissan Motor Co Ltd Vibration absorber of vehicle
FR2529463B1 (fr) * 1982-07-05 1986-01-10 Centre Nat Rech Scient Procede et dispositif pour l'encapsulation dans les erythrocytes d'au moins une substance a activite biologique, notamment des effecteurs allosteriques de l'hemoglobine et erythrocytes ainsi obtenus
FI79330C (fi) * 1982-07-23 1989-12-11 Ciba Geigy Ag Foerfarande foer framstaellning av farmakologiskt verkande muramylpeptid-n-(2-fosfatidyloxietyl)-amider.
US5134230A (en) * 1988-03-02 1992-07-28 Daiichi Pharmaceutical Co., Ltd. 2-Deoxy-2-aminoglucopyranoside derivatives
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
AU4251300A (en) 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2292486A1 (fr) * 1974-07-01 1976-06-25 Anvar Adjuvants immunologiques solubles dans l'eau, notamment pour vaccins, obtenus a partir de microbacteries et autres micro-organismes
CH613709A5 (en) * 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
US4153684A (en) * 1976-03-10 1979-05-08 Agence Nationale De Valorisation De La Recherche (Anvar) Immunizing and anti-infectious adjuvant agents constituted by N-acetyl-muramyl-L-alanyl-D-glutamic acid derivatives
FR2369292A1 (fr) * 1976-11-02 1978-05-26 Anvar Agents adjuvants immunit
JPS52139018A (en) * 1976-03-10 1977-11-19 Anvar Immuno adjuvant and antiinfection adjuvant composed of mainly nnacetyll muramiccllalanyllddglutamic ester or nnacetyllmuramiccllalanylldd isoglutamic ester
FR2355505A1 (fr) * 1976-06-24 1978-01-20 Anvar Nouvel agent adjuvant immunitaire
FR2358159A1 (fr) * 1976-07-16 1978-02-10 Anvar Le diamide de l'acide 2-(2-acetamido-2-deoxy-3 - o-d-glucopyranosyl) - d-propionyl-l-alanyl-d-glutamique et medicaments le contenant
FR2368282A1 (fr) * 1976-10-22 1978-05-19 Anvar Adjuvant immunologique constitue par le p-amino-phenyl de n-acetyl-muramyl-l-alanyl-d-isoglutamine
EP0003833B2 (de) * 1978-02-24 1990-12-19 Ciba-Geigy Ag Antigenderivate, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
FR2428051A1 (fr) 1980-01-04
ATE4719T1 (de) 1983-10-15
PL216102A1 (ru) 1980-03-24
HU184041B (en) 1984-06-28
SU1326197A3 (ru) 1987-07-23
CA1249700A (en) 1989-01-31
CS221505B2 (en) 1983-04-29
IL57476A (en) 1984-06-29
AU4775679A (en) 1979-12-13
ES481785A1 (es) 1980-02-16
US4693998A (en) 1987-09-15
DK150147C (da) 1988-01-18
FR2428051B1 (ru) 1981-12-04
DE2966178D1 (en) 1983-10-27
DK150147B (da) 1986-12-15
SU1346046A3 (ru) 1987-10-15
AU536516B2 (en) 1984-05-10
IL57476A0 (en) 1979-10-31
MA18474A1 (fr) 1979-12-31
AR228240A1 (es) 1983-02-15
EP0006068B1 (fr) 1983-09-21
DK229479A (da) 1979-12-06
EG14154A (en) 1983-09-30
EP0006068A2 (fr) 1979-12-12
DD145274A5 (de) 1980-12-03
PT69725A (fr) 1979-07-01
EP0006068A3 (en) 1980-01-09
JPS55392A (en) 1980-01-05
JPH0233720B2 (ru) 1990-07-30
PL123483B1 (en) 1982-10-30

Similar Documents

Publication Publication Date Title
OA06914A (fr) Procédé de préparation d'iminodiacides substitués.
OA05444A (fr) Procédé de préparation de nouveaux dérivés benzhydrylsulfinyle.
PT69068A (fr) Procede de preparation de nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides
OA06811A (fr) Procédé de préparation de nouveaux dérivés de pyridoxine.
OA05022A (fr) Procédé de préparation de nouveaux dérivés de benzothiophène.
OA06563A (fr) Procédé de préparation de nouveaux dérivés d'indolizine.
OA05445A (fr) Procédé de préparation de nouvelles pyrimidones.
OA06486A (fr) Procédé de préparation de 9 aminoalkylfluorènes.
OA05096A (fr) Procédé de préparation de composés hétérocycliques.
RO82467A (ro) Procedeu pentru prepararea unor 4h-1,3-tiazin-4-one
OA06356A (fr) Procédé de préparation de 2-chlorosulfinylazétidinones.
OA06274A (fr) Procédé de préparation de nouveaux composés de type muramyl-péptide.
OA05385A (fr) Procédé de préparation de nouveaux dérivés phénoxy.
OA05346A (fr) Procédé de préparation de composés hétérocycliques substitués par des groupes acylamino.
OA05405A (fr) Procédé de préparation de composés pharmacologiquement actifs.
OA05605A (fr) Procédé de préparation de nouvelles isobutyramides.
OA05668A (fr) Procédé de préparation de nouvelles aryl trifluoroéthylamines.
OA06355A (fr) Procédé de préparation de 3-exométhylènecépham-sulfoxydes.
MC1036A1 (fr) Procédé de préparation de composés de mercaptopyrrole condensés
OA05260A (fr) Procédé de préparation de dérivés d'histidine.
OA06258A (fr) Procédé de préparation de nouveaux dérivés acétyléniques de l'androst-4-ène.
OA05404A (fr) Procédé de préparation de composés pharmocologiquement actifs.
OA06690A (fr) Composés d'amino-thiadiazolyle, procédé pour leur préparation.
OA06451A (fr) Procédé de préparation de composés B-lactame.
OA05211A (fr) Procédé d'obtention de nouveaux composés de pénicillines.